The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2.
The human T-cell leukemia virus type 2 (HTLV-2), an oncogenic retrovirus closely related to HTLV-1, produces a lifelong infection whose possible association to certain human diseases is still debated. Although some viral products can influence the expression and action of cellular genes, very little is known about the molecular mechanisms involved. Here we show that the AIR-1-encoded human major histocompatibility complex (MHC) class II transactivator (CIITA) strongly inhibits viral replication, but not virus entry, in human B- and T-cell susceptible targets. This effect results from CIITA inhibiting the Tax-mediated transactivation of the HTLV-2 long-term repeat. Further molecular analysis shows that the N-terminal region of CIITA encompassing the first 321 amino acids is responsible for the inhibitory effect on viral replication. This region is crucial for the transactivation of human MHC class II genes and includes the activation domain as well as domains interacting with coactivators that also are used by the viral transactivator Tax to modulate cellular functions. These results represent the first evidence that a cellular transcriptional activator, controlling the coordinate expression of the entire family of MHC class II antigen-presenting molecules, inhibits HTLV-2 viral replication by a distinct mechanism. In this new role CIITA may represent a new tool for therapeutic strategies aimed at counteracting HTLV-2 replication and spreading.
Casoli
Claudio
C
Department of Clinical Medicine, Nephrology, and Health Sciences, School of Medicine, University of Parma; Via Gramsci 14, 43100 Parma, Italy. claudio.casoli@unipr.it
De Lerma Barbaro
Andrea
A
Pilotti
Elisabetta
E
Bertazzoni
Umberto
U
Tosi
Giovanna
G
Accolla
Roberto S
RS
D001402:B-Lymphocytes / Q000276:immunology / Q000821:virology; D001483:Base Sequence; D002460:Cell Line; D004279:DNA, Viral / Q000235:genetics; D016356:Gene Products, tax / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D006367:HeLa Cells; D015367:Human T-lymphotropic virus 2 / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology; D020079:Terminal Repeat Sequences; D015533:Transcriptional Activation; D014779:Virus Replication
D004279:DNA, Viral; D016356:Gene Products, tax